Cargando…
Psoriatic Arthritis during Treatment with Bevacizumab for Anaplastic Oligodendroglioma
Bevacizumab is a recombinant humanised monoclonal antibody directed against the vascular endothelial growth factor (VEGF). The drug, alone or in combination with other anticancer agents, has been shown to be effective against several types of neoplasms. We report a case of a woman with a history of...
Autores principales: | Graceffa, D., Maiani, E., Pace, A., Solivetti, F. M., Elia, F., De Mutiis, C., Bonifati, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517839/ https://www.ncbi.nlm.nih.gov/pubmed/23243547 http://dx.doi.org/10.1155/2012/208606 |
Ejemplares similares
-
Clinical and Contrast-Enhanced Ultrasound Echography Outcomes in Psoriatic Arthritis Patients after One Year of Continuous Therapy with Anti-TNF Drugs
por: Bonifati, Claudio, et al.
Publicado: (2014) -
Complete Radiologic Response in an Anaplastic Oligodendroglioma Treated with Temozolomide and Bevacizumab
por: Katz, Artur, et al.
Publicado: (2009) -
Capillaroscopy in Psoriatic and Rheumatoid Arthritis: A Useful Tool for Differential Diagnosis
por: Graceffa, Dario, et al.
Publicado: (2013) -
Multiple Extraneural Metastases of Anaplastic Oligodendroglioma
por: Aydemir, Fatih, et al.
Publicado: (2018) -
A rare, giant, anaplastic oligodendroglioma
por: Tuan, Pham Anh, et al.
Publicado: (2023)